NCT04132232View on ClinicalTrials.gov

Smoking Reduction In Gravid Substance Use Disorders

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Tobacco Smoking in Mother Complicating PregnancyTobacco Use DisorderTobacco Smoking
Interventions
DIAGNOSTIC_TEST

knowledge of expired maternal carbon monoxide and fetal carboxyhemoglobin levels

Will use the Smokerlyzer® device at each visit and be provided information on exhaled carbon monoxide and fetal carboxyhemoglobin. Risks of adverse perinatal outcomes related to maternal carbon monoxide and fetal carboxyhemoglobin level will be provided.

Trial Locations (1)

35233

University of Alabama, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT04132232 - Smoking Reduction In Gravid Substance Use Disorders | Biotech Hunter | Biotech Hunter